Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Lupin launches Imatinib Mesylate Tablets

Posted On: 2019-07-10 11:13:09


Pharma major Lupin Limited {Lupin) announced the launch of Imatinib Mesylate Tablets, 100 mg {base) and 400 mg {base). Lupin's alliance partner Natco had received an approval from the United States Food and Drug Administration (U.S. FDA) earlier.

Lupin's Imatinib Mesylate Tablets, 100 mg (base) and 400 mg (base), is the generic version of Novartis Pharmaceuticals Corporation's (Novartis) Gleevec® Tablets, 100 mg and 400 mg. It is indicated for the treatment of:

- Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.

- Patients with Philadelphia chromosome positive chronic myeloid leu kemi a (Ph+ CML) in blast crisis (BC), accelerated phase (AP), or in chronic phase (CP) after failure of interferon-alpha therapy.

- Adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia {Ph+ ALL).

- Adult patients with myelodysplastic/myeloproliferative diseases {MDS/MPD) associated wit h PDGFR (plateletderived growth factor receptor) gene re-arrangements as determined with an FDA-approved test.

- Adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-Kit mutation as determined with an FDA-approved test or with c-Kit mutational status unknown.

- Adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia {CEL) who have the FIP1L1-PDGFRa fusion kinase {mutational analysis or FISH demonstration of CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFRa fusion kinase negative or unknown.

- Adult patients with unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans (DFSP). Imatinib Mesylate Tablets, 100 mg {base) and 400 mg (base), had annual sales of approximately USD 548 million in the US (IQVIA MAT May 2019).

Shares of LUPIN LTD. was last trading in BSE at Rs.751.5 as compared to the previous close of Rs. 733.75. The total number of shares traded during the day was 51046 in over 1395 trades.

The stock hit an intraday high of Rs. 753.5 and intraday low of 730.85. The net turnover during the day was Rs. 38072272.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Prism Johnson Ltd posts jump in Q3FY21 consolidated PAT to Rs. 55.24 crore

TCS Voted as the Top Digital Transformation Enabler in Survey of Indian CIOs

Oil India Limited commences first ever seismic survey in the state of Tripura

Dilip Buildcon Ltd - AHC JV signs EPC agreement with NHAI for road project in Rajasthan

Zydus granted Orphan Drug Designation by the USFDA for Saroglitazar in the treatment of patients with Primary Biliary Cholangitis (PBC)

Mr. Rajnikant D. Shroff, Chairman and Managing Director of UPL Ltd. conferred Padma Bhushan

Glenmark Pharmaceuticals receives ANDA approval for Amphetamine Sulfate Tablets USP, 5 mg and 10 mg

Infosys Expands Relationship with Snowflake to Become Elite Service Partner

Quess Corp Limited approves investment in TaskMo, a digital gig worker platform

A. K. Capital Services Limited board declares interim dividend of Rs. 5 for FY21

SVP Global to raise ~ Rs 235 Cr via Equity Warrants, convertible at 37% premium to market price

Quess Corp Ltd Q3FY21 consolidated PAT at Rs. 41.75 crore

A K Capital Services Ltd Q3FY21 consolidated net profit zooms to Rs. 31.61 crore

Bhageria Industries Ltd Q3FY21 consolidated net profit rises to Rs. 22.48 crore

HUL announces key appointment to its Management Committee

Manorama Industries Limited recognized by Fair Trade and Fair for Life Certifications for its ESG Practices

Greenply Industries Ltd completes assessment conducted by Great Place to Work Institute

PVR Ltd opens QIP, fixes floor price as Rs. 1495.93 per share

CRISIL upgrades long-term rating of Endurance Technologies Limited

Aditya Birla Fashion and Retail Limited to acquire 51% in Sabyasachi Couture

Trio Mercantile & Trading Ltd Board recommends sub-division & bonus issue of equity shares

TATA Coffee Ltd Q3FY21 consolidated net profit climbs to Rs. 31.52 crore

United Spirits Ltd posts consolidated PAT of Rs. 287 crore in Q3 FY2020-21

Suraj Products Ltd Q3FY21 net profit zooms to Rs. 3.39 crore

Swastika Investmart Ltd reports Q3FY21 consolidated PAT of Rs. 2.42 crore

Cosmo Films Ltd board declares interim dividend of Rs. 25

Datamatics simplifies document processing with a new AI-enabled TruCap+ IDP solution

GMR Hyderabad International Airport Limited successfully prices $300 mn bond offering

ICICI Prudential Life Insurance Company Ltd reports Q3FY21 consolidated PAT of Rs. 304.30 crore

Lakshmi Machine Works Ltd Q3FY21 consolidated PAT surges to Rs. 33.26 crore

JK Paper Ltd reports Q3FY21 consolidated PAT of Rs. 65.94 crores

Titan Securities Ltd posts Rs. 2.67 crore consolidated PAT in Q3

Bannari Amman Sugars Ltd Q3FY21 net profit at Rs. 31.92 crores

Vakrangee Limited included in 2021 Bloomberg Gender-Equality Index

Government to divest MMTC Ltd's JV, Neelachal Ispat Nigam Ltd

Stylam Industries Ltd board to consider stock split on Feb 9, 2021

Cosmo Films Ltd posts Rs. 62.75 crores consolidated PAT in Q3 FY2020-21

Bella Casa Fashion & Retail Ltd board declares interim dividend of Rs. 0.60

Affle announces the global launch of Appnext OOBE platform powered by the acquisition of DiscoverTech

Hero MotoCorp partners with Grupo Salinas in Mexico

POWERGRID to sell units in POWERGRID Infrastructure Investment Trust

NALCO board approves buyback of equity shares at Rs. 57.50 per share

HOCL Q3FY21 consolidated PAT at Rs. 14.79 crore

Duncan Engineering Ltd Q3 net profit at Rs. 1.12 crore

Bella Casa Fashion & Retail Ltd reports Rs. 4 crore PAT in Q3

Titan Biotech Ltd posts Rs. 6.62 crore consolidated net profit in Q3FY21

Surya Roshni Ltd Q3FY21 consolidated PAT jumps to Rs. 55.62 crore

AXIS Bank Ltd reports Q3FY21 consolidated PAT of Rs. 1334.84 crores

Zodiac JRD MKJ Ltd Q3FY21 net profit at Rs. 0.13 crore

Mrs. Rajni Bector conferred with Padma Shri for her contribution to trade and industry



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020